Migraine History Tied to Higher Risk for Adverse Pregnancy Outcomes

THURSDAY, June 2, 2022 (HealthDay News) -- A self-reported migraine history is associated with a higher risk for some adverse pregnancy outcomes, according to a research letter published online April 30 in the American Journal of Obstetrics & Gynecology.
Eliza C. Miller, M.D., from Columbia University in New York City, and colleagues assessed whether self-reported migraine in nulliparous individuals is associated with higher odds of adverse pregnancy outcomes. The analysis included 9,450 nulliparous U.S. individuals with singleton gestation in early pregnancy followed through delivery.
The researchers found that 19.1 percent of participants reported a diagnosis of migraine at the first visit. White race, recent smoking history, autoimmune disorders, and chronic kidney disease were more common among participants with migraine. In an adjusted analysis, participants with migraine had increased odds of any adverse pregnancy outcome (adjusted odds ratio, 1.26), as well as any hypertensive disorder of pregnancy and both medically indicated and spontaneous preterm birth. A larger effect was seen in participants who reported recent medication use (adjusted odds ratio, 1.49).
"In a diverse, prospective cohort of 9,450 nulliparous U.S. participants, self-reported migraine headaches were associated with 26 percent higher odds of adverse pregnancy outcomes -- an effect driven by hypertensive disorders of pregnancy and both medically indicated and spontaneous preterm birth," the authors write. "Migraine may be an underrecognized risk factor for adverse pregnancy outcomes."
Related Posts
Para la salud cardiaca, hay un mejor momento del día para que las mujeres hagan ejercicio
LUNES, 21 de noviembre de 2022 (HealthDay News) -- Hace mucho que se afirma que...
Persistent Opioid Use After Sarcoma Treatment Explored Among Youth
TUESDAY, May 24, 2022 (HealthDay News) -- Twenty-three percent of adolescents...
FDA Says Gene-Edited Cattle Are Safe to Eat
TUESDAY, March 8, 2022 (HealthDay News) -- The U.S. Food and Drug Administration...
Pfizer, Moderna COVID-19 Shots Work for Children Under 5, FDA Says
MONDAY, June 13, 2022 (HealthDay News) -- Antibody levels suggest that three...